Senescent Cells: What "Zombie Cells" Are and Why They Matter for Aging

Senescent cells are cells that have permanently stopped dividing but don't die. Often called "zombie cells," they keep releasing inflammatory signals that can affect the tissue around them. They build up with age, and researchers count cellular senescence as one of the 12 hallmarks of aging. In mice, removing them extended healthy life. Human studies are early.

The phrase "zombie cells" makes senescence sound like a horror story. The real picture is more interesting. Senescence is a safety system your body needs. It only becomes a problem when the cells it creates pile up faster than they're cleared. This guide covers what senescent cells are, why they form, what the mouse and human research actually shows and what's reasonable to do about it today.

Last reviewed: October 26, 2026.

Key Takeaways

• A senescent cell has stopped dividing for good but stays alive and active, releasing a mix of signals called the SASP (senescence-associated secretory phenotype).
• Senescence protects you in the short term. It stops damaged cells from multiplying and plays roles in embryo development and tissue repair.
• Senescent cells become more common with age, though the amount varies a lot by tissue, according to a 2020 meta-analysis of human tissue studies.
• Clearing senescent cells extended median lifespan and delayed age-related decline in mice. Human trials of senolytic drugs are small, and a 2024 randomized trial in older women found only limited effects.
• No supplement has been shown to clear senescent cells in people. In one human study, a 12-week exercise program lowered blood markers of senescence in older adults.

What are senescent cells?

Most cells in your body divide, do their job and, when damaged beyond repair, self-destruct. A senescent cell takes a third path. It enters a stable state of cell-cycle arrest: it stops dividing, resists dying and changes how it behaves. The International Cell Senescence Association, a group of leading researchers, describes senescence as a cell state involved in normal body processes and in a wide range of age-related conditions (Gorgoulis et al., 2019).

The idea goes back to 1961. Leonard Hayflick and Paul Moorhead found that normal human cells grown in a lab dish can only divide a limited number of times before they stop (Hayflick and Moorhead, 1961). That ceiling became known as the Hayflick limit. Researchers later found that many kinds of stress, not just repeated division, can push a cell into the same state.

The NIH, which funds a national research network on these cells, puts it plainly. As we age, our tissues gather a small number of cells that no longer divide. Under some conditions they release molecules that can damage nearby tissue. Under others, such as wound healing and limiting tumor growth, they play protective roles (NIH Common Fund, SenNet).

Why are they called "zombie cells"?

Because they're stuck between alive and dead. A senescent cell no longer does the work of a healthy, dividing cell, yet it doesn't die and get cleared away. It also keeps "talking" to its neighbors.

That chatter is the SASP. In a 2008 study, researchers at Lawrence Berkeley National Laboratory showed that human cells pushed into senescence by DNA damage released a large set of factors linked with inflammation, including the signaling proteins IL-6 and IL-8 (Coppé et al., 2008). The National Institute on Aging puts the big picture simply: as we age, some damaged cells stop dividing but don't die off, they accumulate over time, and they contribute to inflammation (National Institute on Aging).

What triggers cellular senescence?

Senescence is a response to stress or damage. The main triggers researchers describe include:

• Repeated division. Each division shortens telomeres, the protective caps on chromosomes. Eventually the cell stops dividing, the limit Hayflick first saw.
• DNA damage. Enough DNA damage, including damage from some chemotherapy drugs, can trigger senescence, as the 2008 SASP study showed (Coppé et al., 2008).
• Cancer-promoting gene changes. Switching on a growth-driving gene called RAS pushes normal cells into senescence, halting them before they multiply (Coppé et al., 2008).
• Other cellular stress. Researchers describe senescence broadly as a response to damaging stimuli, and say senescent cells can arise throughout the lifespan (Chaib et al., 2022).

Is cell senescence good or bad?

Both. It depends on timing and on whether the cells get cleared.

In the embryo, senescent cells appear on schedule, do their job and are then removed by immune cells called macrophages (Storer et al., 2013). That's the healthy version: a short-lived signal that is cleaned up afterward. The trouble starts when the cleanup falls behind.

At what age does senescence start?

There's no single starting age. Senescent cells can form at any point in life, from the embryo onward (Storer et al., 2013; Chaib et al., 2022). What changes with age is how many stick around.

A 2020 systematic review and meta-analysis pooled studies that measured senescence in human tissue samples. Senescence was higher in older tissue, but the amount varied widely by tissue type, by tissue section and by the marker used to detect it (Tuttle et al., 2020). In other words, scientists can see the trend, but there isn't a clean timeline.

How are senescent cells linked to aging?

In 2023, a widely cited review in Cell listed 12 hallmarks of aging, the biological processes that change with age and appear to drive it. Cellular senescence is one of them, alongside telomere attrition, mitochondrial dysfunction and chronic inflammation (López-Otín et al., 2023). The hallmarks are interconnected. For example, the inflammatory SASP overlaps with the chronic inflammation hallmark. If you want the bigger picture, our guide to healthspan vs. lifespan explains why researchers care more about years of good health than raw lifespan.

The strongest evidence that senescent cells matter comes from mice:

• 2011, fast-aging mice. Mayo Clinic researchers built mice whose senescent cells could be destroyed on demand. Lifelong removal delayed age-related changes in fat tissue, muscle and the eye. Clearing the cells later in life slowed changes that had already begun (Baker et al., 2011).
• 2016, normal mice. The same approach in ordinary mice, starting at one year of age, extended median lifespan in both males and females. It also delayed age-related decline in the kidney, heart and fat tissue, with no obvious side effects (Baker et al., 2016).
• 2018, transplant studies. Transplanting a small number of senescent cells into young mice caused lasting physical decline and spread senescence to the host's tissue. In older mice, an intermittent senolytic drug combination improved physical function and increased survival after treatment by 36% (Xu et al., 2018).

Mice aren't people. These studies show senescent cells can drive decline in animals. They don't show what removing them would do for a healthy human.

Can senescent cells become cancerous?

Senescence itself is one of the body's ways of stopping cancer. It locks a damaged cell out of dividing (Baker et al., 2011). The concern is indirect. In lab studies, signals released by senescent cells pushed nearby precancerous cells toward invasive behavior (Coppé et al., 2008). In the 2016 mouse study, clearing senescent cells delayed the appearance of tumors (Baker et al., 2016). How this plays out in people is still being studied. If you have questions about cancer risk, talk to your doctor.

What are senolytics, and do they work in people?

Senolytics are drugs designed to make senescent cells self-destruct. Many senescent cells survive by switching on internal defenses against cell death. Senolytics briefly disable those defenses (Kirkland and Tchkonia, 2020). The first ones studied were dasatinib (a prescription cancer drug), quercetin and fisetin (plant compounds called flavonoids) and navitoclax. Because senescent cells take weeks to build back up, researchers test them on an intermittent "hit-and-run" schedule rather than every day.

Human results so far are limited:

The NIA summed up the 2024 trial this way: there isn't yet clear evidence supporting senolytics for bone health or broader healthy aging goals (NIA, 2025). The researchers who discovered the first senolytics have written that it's too early for them to be used outside clinical trials (Kirkland and Tchkonia, 2020). It's also worth knowing that Mayo Clinic holds patents on senolytic drugs, and the Mayo researchers behind several of these studies disclose a financial interest in their papers.

Are there supplements that remove senescent cells?

Not that have been shown to in people. Quercetin and fisetin are sold as supplements, which is why you'll see "senolytic" products online. But the human senolytic studies above paired quercetin with dasatinib, a prescription drug, at doses and schedules set by researchers. Researchers running a 2026 fisetin trial note that fisetin, which is found in fruits and vegetables, has shown anti-inflammatory effects in lab studies, but evidence of its effects in humans is limited (Tavenier et al., 2026).

So treat any product that promises to "flush out zombie cells" with caution. If you want to understand what longevity supplements can and can't do, our longevity supplements guide walks through the evidence, and our guide to reading a Supplement Facts label shows how to check what's actually in a bottle.

How do you get rid of senescent cells naturally?

Your immune system already clears many senescent cells. That's what happens to them in the embryo (Storer et al., 2013). Nobody can yet prescribe a lifestyle plan proven to cut your senescent cell count. But one habit has early human data behind it.

In a 2021 Mayo Clinic study, older adults followed a 12-week structured exercise program. Their physical function improved, and markers of senescence fell. Those markers included the genes p16 and p21 in immune T cells, plus several senescence-related proteins in the blood (Englund et al., 2021). The authors called it first-in-human evidence that exercise lowers biomarkers of senescent cell burden. It measured markers, not the cells in tissue, and it was a single program. Still, it fits everything else we know about exercise and aging. Our article on exercise and longevity covers how much activity the research supports.

Can senescent cells be reversed?

Not in any practical sense today. Senescence is defined by a stable stop to cell division (Gorgoulis et al., 2019). Research has focused on removing the cells with senolytic drugs and on other senescence-targeting approaches. All of them are still being tested in humans (Chaib et al., 2022).

Can you test for senescent cells?

Not with a routine clinical test. Senescent cells are rare and varied, and there's no single specific marker for them (Li et al., 2025). Building reliable ways to find and map them in human tissue is the main goal of the NIH's Cellular Senescence Network (NIH Common Fund, SenNet). Be skeptical of any consumer test that claims to count your "zombie cells." Our guide to biological age tests explains what today's aging tests can and can't tell you.

What can you do today?

None of these steps targets senescent cells directly. They're the habits with the broadest evidence for healthy aging, and they're what the research above points toward:

• Move regularly. Structured exercise is the one habit with human data on senescence markers (Englund et al., 2021).
• Eat a mostly whole-food diet. No single food has been shown to clear senescent cells in people. Overall eating patterns have the best evidence for long life. See our guide to diet and longevity.
• Protect your sleep. See sleep and aging for what the research shows.
• Don't self-experiment with senolytic drugs. Dasatinib is a prescription cancer drug. The researchers developing senolytics say they belong in clinical trials for now (Kirkland and Tchkonia, 2020).
• Follow the trials, not the hype. Clinical trials of senolytics are underway (Kirkland and Tchkonia, 2020). If you're thinking about joining one, talk to your doctor first.

Frequently Asked Questions

What is cellular senescence in simple terms?

It's when a cell permanently stops dividing but doesn't die. It stays in the tissue and releases signals, some of them inflammatory, that affect nearby cells.

Are zombie cells and senescent cells the same thing?

Yes. "Zombie cells" is a nickname for senescent cells, because they're neither fully functioning nor dead.

What is the SASP?

SASP stands for senescence-associated secretory phenotype. It's the mix of inflammatory and other molecules a senescent cell releases, including IL-6 and IL-8.

Do senescent cells cause aging?

They're considered one of 12 hallmarks of aging. In mice, removing them delayed age-related decline and extended median lifespan. Whether the same holds in people isn't known yet.

Can exercise reduce senescent cells?

In one 12-week study of older adults, structured exercise lowered blood and immune-cell markers of senescence. That's encouraging, but it measured markers rather than counting the cells in tissue.

Do senolytic supplements work?

There's no good evidence that over-the-counter "senolytic" supplements clear senescent cells in people. Human studies so far are small and mostly used a prescription drug combination.

What foods slow cellular aging?

No specific food has been shown to slow cellular senescence in people. The best evidence for long life is about overall eating patterns built mostly on vegetables, legumes, whole grains, fruit and nuts.

Sources

• López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: An expanding universe. Cell. 2023.
• Gorgoulis V, Adams PD, Alimonti A, et al. Cellular Senescence: Defining a Path Forward. Cell. 2019.
• Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res. 1961.
• Coppé JP, Patil CK, Rodier F, et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 2008.
• Storer M, Mas A, Robert-Moreno A, et al. Senescence is a developmental mechanism that contributes to embryonic growth and patterning. Cell. 2013.
• Baker DJ, Wijshake T, Tchkonia T, et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature. 2011.
• Baker DJ, Childs BG, Durik M, et al. Naturally occurring p16Ink4a-positive cells shorten healthy lifespan. Nature. 2016.
• Xu M, Pirtskhalava T, Farr JN, et al. Senolytics improve physical function and increase lifespan in old age. Nat Med. 2018.
• Tuttle CSL, Waaijer MEC, Slee-Valentijn MS, et al. Cellular senescence and chronological age in various human tissues: A systematic review and meta-analysis. Aging Cell. 2020.
• Kirkland JL, Tchkonia T. Senolytic drugs: from discovery to translation. J Intern Med. 2020.
• Chaib S, Tchkonia T, Kirkland JL. Cellular senescence and senolytics: the path to the clinic. Nat Med. 2022.
• Justice JN, Nambiar AM, Tchkonia T, et al. Senolytics in idiopathic pulmonary fibrosis: Results from a first-in-human, open-label, pilot study. EBioMedicine. 2019.
• Hickson LJ, Langhi Prata LGP, Bobart SA, et al. Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease. EBioMedicine. 2019.
• Farr JN, Atkinson EJ, Achenbach SJ, et al. Effects of intermittent senolytic therapy on bone metabolism in postmenopausal women: a phase 2 randomized controlled trial. Nat Med. 2024.
• Englund DA, Sakamoto AE, Fritsche CM, et al. Exercise reduces circulating biomarkers of cellular senescence in humans. Aging Cell. 2021.
• Tavenier J, Berglind M, Hach LF, et al. Low-Dose Fisetin Supplementation and Its Association With Chronic Inflammation in Middle-Aged and Older Adults: Study Protocol for a Triple-Blind, Randomised, Placebo-Controlled Trial. Basic Clin Pharmacol Toxicol. 2026.
• Li S, Agudelo Garcia PA, Aliferis C, et al. Advancing biological understanding of cellular senescence with computational multiomics. Nat Genet. 2025.
• National Institute on Aging. Senolytic therapy shows subtle impact on age-related bone health in women. 2025.
• NIH Common Fund. Cellular Senescence Network (SenNet).

Disclosure: OPA Nutrition sells supplements, including products mentioned in this article. This content is for education only and is not medical advice. Statements about dietary supplements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Talk to your healthcare provider before using any supplement, especially if you take medication or have a medical condition.